Key Facts

Lilly at a Glance

• A heritage 147 years strong: company founded on May 10, 1876 

• Headquarters located in Indianapolis, Indiana, U.S.A. 

• More than 42,000 employees worldwide 

• Approximately 10,000 employees engaged in research and development 

• Clinical research conducted in more than 55 countries 

• Research and development facilities located in 7 countries 

• Manufacturing plants located in 9 countries

• Products marketed in approximately 110 countries

Employees

as of December 31, 2023

• Indianapolis: 12,049

• Indiana (excluding Indianapolis): 196

• U.S. (excluding Indiana): 7,631

• Outside U.S.: 23,102

• Worldwide total: 42,978

2023 Financials

dollars in millions, except per-share data

• Revenue: $34,124.1 

• Net income as reported: $5,240.4  

• Net income non-GAAP: $5,712.5 

• Earnings per share (diluted) as reported: $5.80

• Earnings per share (diluted) non-GAAP: $6.32 

• Dividends paid per share: $4.52 

Research & Development

2023 Expenditures

• $9,313.4 million

• R&D as a percentage of sales: 27.3% 

• Employees engaged in R&D activities: 10,219

• Percentage of total workforce: 23.9%

Cost of Pharmaceuticals

• Average cost to discover and develop a new drug: $2.6 billion

• Average length of time from discovery to patient: 10 years